# name
Reassessing the status of antiphospholipid syndrome in systemic lupus erythematosus.

# metadata.dc.contributor.author[].value
Hughes, Graham R. V. (Graham Robert Vivian)

# metadata.dc.description.abstract[].value
The antiphospholipid syndrome was initially described in 1986. To reassess the validity of antiphospholipid antibodies in systemic lupus erythematosus (SLE), 95 patients with SLE were studied. Their antiphospholipid antibody profile was analysed and correlated with clinical findings such as thrombosis, abortions, or thrombocytopenia. A low prevalence of these antibodies was found (13 patients; 14%) with a high specificity for thrombosis (92%) and abortions (92%). The importance of anticardiolipin antibodies as a risk factor for thrombosis or abortions, or both, in patients with SLE is reaffirmed by this work.

# metadata.dc.relation.ispartof[].value
Annals of the Rheumatic Diseases, 1992, vol. 51, núm. 2, p. 160-161

# metadata.dc.source[].value
Articles publicats en revistes (Medicina)

# metadata.dc.title[].value
Reassessing the status of antiphospholipid syndrome in systemic lupus erythematosus.